Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | IVP | Class A Common Stock | 22.7K | Aug 29, 2023 | Direct | ||||||
holding | IVP | Class B Common Stock | 2.15M | Aug 29, 2023 | See footnote | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | IVP | Class B Common Stock | Aug 29, 2023 | Class A Common Stock | 2.15M | See footnote | F1, F2, F3 |
Id | Content |
---|---|
F1 | Shares of Class B common stock are held by Wilderness Trace Veterinary Partners, LLC, which is 100% owned and controlled by Charles Stith Keiser, the issuer's Director and Chief Operating Officer. |
F2 | Following consummation of the initial public offering, Mr. Keiser owns less than 10% of all outstanding shares of Class A common stock, approximately 18.9% of all shares of common stock outstanding (Class A and Class B, collectively) and approximately 46.9% of the voting control of the registrant, prior to the conversion or election of any outstanding convertible securities or warrants of the issuer. |
F3 | Each share of Class B common stock is entitled to the same rights applicable to each share of Class A common stock, except each share of Class B common stock is entitled to 25 votes per share of Class B common stock and is convertible at the option of the holder, at any time and from time to time, without the payment of additional consideration, into one share of Class A common stock. |